Parkinson disease is commonly recognized as a neurodegenerative disorder that leads to disabling motor and cognitive impairment, but less widely appreciated is the association of this condition with a variety of pain syndromes. A recent survey emphasizes the high prevalence and severity of pain in patients with Parkinson disease.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson’s disease: implication of acrolein and TRPA1
Translational Neurodegeneration Open Access 28 April 2021
-
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
Neurological Research and Practice Open Access 26 August 2019
-
A Key Role of the Basal Ganglia in Pain and Analgesia - Insights Gained through Human Functional Imaging
Molecular Pain Open Access 13 May 2010
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Beiske, A. G., Loge, J. H., Ronningen, A. & Svensson, E. Pain in Parkinson's disease: prevalence and characteristics. Pain 141, 173–177 (2009).
Parkinson, J. An Essay on the Shaking Palsy (Sherwood Neely Jones, London, 1817).
Souqes, M. A. Pain in paralysis agitans [French]. Rev. Neurol. 37, 629–633 (1921).
Quinn, N. P., Lang, A. E., Koller, W. C. & Marsden, C. D. Painful Parkinson's disease. Lancet 1, 1366–1369 (1986).
Tinazzi, M. et al. Pain and motor complications in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 77, 822–825 (2006).
Defazio, G. et al. Pain as a nonmotor symptom of Parkinson's disease: evidence from a case–control study. Arch. Neurol. 65, 1191–1194 (2008).
Negre-Pages, L. et al. for the DoPaMiP Study Group. Chronic pain in Parkinson's disease: the cross-sectional French DoPaMiP survey. Mov. Disord. 23, 1361–1369 (2008).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Ford, B. Pain in Parkinson disease: the hidden epidemic. Nat Rev Neurol 5, 242–243 (2009). https://doi.org/10.1038/nrneurol.2009.50
Issue Date:
DOI: https://doi.org/10.1038/nrneurol.2009.50
This article is cited by
-
Acrolein scavenger dimercaprol offers neuroprotection in an animal model of Parkinson’s disease: implication of acrolein and TRPA1
Translational Neurodegeneration (2021)
-
Conditioned pain modulation in drug-naïve patients with de novo Parkinson’s disease
Neurological Research and Practice (2019)
-
Mental health in Parkinson’s disease after receiving aquatic therapy: a clinical trial
Acta Neurologica Belgica (2019)
-
Integrated Approach for Pain Management in Parkinson Disease
Current Neurology and Neuroscience Reports (2016)
-
Management of Motor and Non-Motor Symptoms in Parkinson’s Disease
CNS Drugs (2013)